Stopping immunomodulatory medications in MS: Frequency, reasons and consequences

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Prolonged periods of disease quiescence during long term treatment of patients with clinically isolated syndrome and MS may prompt consideration of discontinuing disease-modifying therapy (DMT). We reviewed pertinent studies to identify the frequency and reasons for discontinuation of DMT.

Original languageEnglish (US)
Pages (from-to)437-443
Number of pages7
JournalMultiple Sclerosis and Related Disorders
Volume4
Issue number5
DOIs
StatePublished - Sep 1 2015

Keywords

  • Disease activity
  • Multiple sclerosis
  • Treatment discontinuation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Fingerprint Dive into the research topics of 'Stopping immunomodulatory medications in MS: Frequency, reasons and consequences'. Together they form a unique fingerprint.

Cite this